Search
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: ganglioglioma

NCT Trial Name# of Centers

NCT00978458

  Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
168

NCT01922076

  WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
18

NCT00276640

  Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
13

NCT01514201

  Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
11

NCT00602667

  Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
6

NCT01462695

  Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
5

NCT03355794

  A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
4

NCT01189266

  Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
3

NCT01188096

  A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
2

NCT03152318

  A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
2

NCT03194906

  Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
1

NCT03593993

  A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
1

NCT01288235

  Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
1

NCT01393912

  PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
1

NCT01517776

  Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
1

NCT01644773

  Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
1

NCT01999270

  Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
1

NCT02031965

  Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
1

NCT02233049

  Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
1

NCT02451215

  Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors
1

NCT02607124

  A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy
1

NCT02507232

  A Phase II Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
1

NCT03115164

  Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics
1

Brain Tumor News Articles About ganglioglioma

  1. [11/19/2013] Tumor Paint: Changing the way surgeons fight cancer  One of my favorite doctors.. nice story

  2. [07/20/2004] Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.

  3. [06/29/2004] Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.

  4. [01/27/2004] Surgical Outcome following Resection of Contrast-Enhanced Pediatric Brainstem Gliomas.

  5. [11/11/2003] Postoperative regression of desmoplastic infantile gangliogliomas: report of two cases.

  6. [05/26/2002] Safety profile and activity of high-dose temozolomide given daily x 3 every 2 weeks in patients with primary brain tumors. Temador was given safely at escalated dosages on days 1-3 and 14-16 every 28 days.





Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740